SYMBICORT 80/4.5 and 160/4.5 were already approved in the US to treat asthma in patients 12 years and older. In September 2017, SYMBICORT160/4.5 was approved for reducing exacerbations in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results